Back to all peptides
Muscle & Growth Hormone

CJC-1295

Modified GRF 1-29 · with or without DAC
researchmainstreamsubQ injection

What it is

CJC-1295 is a modified version of GHRH (growth hormone-releasing hormone). Two versions exist:

How it works

Both versions stimulate GHRH receptors in the pituitary, telling it to release growth hormone. The "no-DAC" version produces natural pulses; the "with-DAC" version produces a continuous GH "bleed" — some users find this less natural-feeling but more convenient.

Almost always paired with a GHRP (Ipamorelin is the cleanest choice) because the two work via different pituitary receptors and produce a much stronger combined GH release than either alone.

Benefits

Timeline

Week 1–2
Improved sleep within days; some water retention.
Week 4–6
Body composition starting to shift; better recovery.
Week 8–12
Visible lean mass and fat loss; peak IGF-1 reached.
Month 3–6
Plateau — cycle off to resensitize receptors.

Dosing & titration

CJC-1295 no-DAC100–200 mcg, 1–3x daily, paired with Ipamorelin
CJC-1295 with DAC1–2 mg subQ, once per week
Cycle length8–12 weeks on, 4 weeks off
TimingEmpty stomach. Pre-bed for the no-DAC version aligns with natural pulse.
When to titrate upMost users see good results at 100–200 mcg with no-DAC. With DAC, 2 mg/week is the upper end — higher provides little extra benefit and increases side effects.

Side effects & risks

Get baseline IGF-1. The DAC version raises IGF-1 well above natural pulsatile levels — long-term, the no-DAC version is generally considered safer.

Typical price

$80–$160/mo5 mg vial from a 503A compounding pharmacy. Most commonly sold as a CJC-1295/Ipamorelin pre-mixed blend.

Studies

Educational reference only. Not medical advice. Not FDA-approved.